GI-19007, a Novel Saccharomyces cerevisiae-Based Therapeutic Vaccine against Tuberculosis.
- DOI
- 10.1128/cvi.00245-17
- Published
- 2017 Dec
- Container
- Clinical and vaccine immunology : CVI
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1128/cvi.00245-17,
title = {GI-19007, a Novel Saccharomyces cerevisiae-Based Therapeutic Vaccine against Tuberculosis.},
author = {King TH and Shanley CA and Guo Z and Bellgrau D and Rodell T and Furney S and Henao-Tamayo M and Orme IM},
year = {2017},
journal = {Clinical and vaccine immunology : CVI},
doi = {10.1128/cvi.00245-17},
url = {https://doi.org/10.1128/cvi.00245-17}
}RIS
TY - JOUR TI - GI-19007, a Novel Saccharomyces cerevisiae-Based Therapeutic Vaccine against Tuberculosis. AU - King TH AU - Shanley CA AU - Guo Z AU - Bellgrau D AU - Rodell T AU - Furney S AU - Henao-Tamayo M AU - Orme IM PY - 2017 JO - Clinical and vaccine immunology : CVI DO - 10.1128/cvi.00245-17 UR - https://doi.org/10.1128/cvi.00245-17 ER -
APA
TH, K., CA, S., Z, G., D, B., T, R., S, F., M, H., & IM, O. (2017). GI-19007, a Novel Saccharomyces cerevisiae-Based Therapeutic Vaccine against Tuberculosis.. Clinical and vaccine immunology : CVI. https://doi.org/10.1128/cvi.00245-17
Source records
- pubmed · retrieved 2026-09-27T09:27:32.444Z